News

Tech device nerds are buzzing. Apple (NASDAQ: AAPL) just unveiled its new, AI-capable iPhone 16s. However, the excitement isn’t just around the devices themselves; investors are also talking

Summit Therapeutics Inc. (NASDAQ: SMMT) has seen a meteoric rise this month, surging over 106% after releasing positive clinical trial results for its experimental cancer therapy. Year-to-date

Treasury bonds are the cornerstone of many investment portfolios, offering investors a safe and reliable way to invest in the U.S. government. These long-term debt securities are backed by the

Arm Holdings (NASDAQ: ARM) is a renowned semiconductor IP designer whose chips power billions of devices worldwide. Arm has recently caught the eye of investors, surging in value on the back of a

Sector-oriented exchange-traded funds (ETFs) offer a way to gain exposure to an entire portfolio of companies that may be benefiting from trends in the market. They provide diversification from

Roblox (NYSE: RBLX) has become one of the world’s most popular video games over the past several years. Based on average monthly users among PC games, the game ranked second in July this year

After a prolonged consolidation and downtrend following the pandemic-driven surge, the biotechnology sector is readying for a potential breakout and shifting its narrative. Represented by the

Dave & Buster’s (NASDAQ: PLAY) stock surged more than 10% after its Q2 earnings release because the narrative went something like this: the company is growing, but growth is weak, and expectations

Whenever investors think of how to get exposure to a stock’s direction, they typically only think of buying or selling a stock. However, professionals tend to delve a bit deeper into their views

Analysts reset their expectations for stocks like CrowdStrike (NASDAQ: CRWD), Lululemon (NASDAQ: LULU), Celsius Holdings (NASDAQ: CELH), and Five Below (NASDAQ: FIVE) following the Q2 earnings

Super Micro Computer's (NASDAQ: SMCI) delayed annual filing is a warning to investors that something isn’t right. However, the stock is down 65% from its highs, suggesting the absolute worst has

Markets will always have a reason to keep the market going, and always come up with reasons as to why a stock might be falling, whether these reasons are valid or not. Today, investors need to cut

Alnylam Pharmaceuticals (NASDAQ: ALNY) stock price action has been volatile but is uptrending and has gained 100% in the last two years. The uptrend is driven by increasing expectations for

The reading of August CPI data led the market to sell off because it was as expected. As much hope as there was for aggressive interest rate cuts this year, the FOMC would unlikely follow through